You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Baxter
Express Scripts
Colorcon
Harvard Business School

Last Updated: April 3, 2020

DrugPatentWatch Database Preview

POTASSIUM CITRATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Potassium Citrate, and when can generic versions of Potassium Citrate launch?

Potassium Citrate is a drug marketed by Ut Sw Medctr, Ani Pharms Inc, Mountain, Strides Pharma, Teva Pharms Usa Inc, and Zydus Pharms. and is included in six NDAs.

The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.

US ANDA Litigation and Generic Entry Outlook for Potassium Citrate

A generic version of POTASSIUM CITRATE was approved as potassium citrate by MOUNTAIN on June 9th, 2006.

  Start Trial

Drug patent expirations by year for POTASSIUM CITRATE
Drug Prices for POTASSIUM CITRATE

See drug prices for POTASSIUM CITRATE

Recent Clinical Trials for POTASSIUM CITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
TakedaPhase 3
Xijing Hospital of Digestive DiseasesPhase 4
Sultan Qaboos UniversityPhase 1/Phase 2

See all POTASSIUM CITRATE clinical trials

Pharmacology for POTASSIUM CITRATE
Medical Subject Heading (MeSH) Categories for POTASSIUM CITRATE
Synonyms for POTASSIUM CITRATE
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:?)
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:3)
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt
1334-EP2380568A1
7778-49-6
866-84-2
86R1NVR0HW
A841790
ACALKA
AKOS015918285
anhydrous potassium citrate
anhydrous tripotassium citrate
C6H5K3O7
C6H5O7.3K
CCRIS 6566
CHEBI:64733
CHEMBL1200458
citric acid tripotassium salt (anh.)
citric acid tripotassium salt (anhydrous)
Citric acid, potassium salt
Citric acid, tripotassium salt
CTK3E8103
DB09125
DTXSID8027325
E-332(II)
E332
EC 212-755-5
EINECS 212-755-5
EINECS 231-905-0
FT-0653076
HSDB 1248
INS NO.332(II)
INS-332(II)
K citrate
K544
Kajos
Kaliksir
KSC448C0H
Litocit
LS-177940
Polycitra K
Porekal
potassium 2-hydroxypropane-1,2,3-tricarboxylate
potassium citrate (anh.)
Potassium Citrate (anhydrous)
Potassium citrate anhydrous
Potassium tribasic citrate
Potassiumcitrate
Q419921
Q781
QEEAPRPFLLJWCF-UHFFFAOYSA-K
RTR-024823
Seltz-K
TR-024823
tri potassium citrate
tripotassium 2-hydroxypropane-1,2,3-tricarboxylate
tripotassium 2-oxidanylpropane-1,2,3-tricarboxylate
TRIPOTASSIUM CITRATE
tripotassium citrate (anh.)
tripotassium citrate (anhydrous)
tripotassium citrate anhydrous
UNII-86R1NVR0HW
Urocit K

US Patents and Regulatory Information for POTASSIUM CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ut Sw Medctr POTASSIUM CITRATE potassium citrate FOR SOLUTION;ORAL 019647-002 Oct 13, 1988 DISCN Yes No   Start Trial   Start Trial   Start Trial
Strides Pharma POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 206813-001 Sep 11, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 212779-002 Jan 14, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa Inc POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 209758-003 Mar 5, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Strides Pharma POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 206813-002 Sep 11, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Baxter
Express Scripts
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.